BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31907052)

  • 21. Absence of lung fibrosis after a single pulmonary delivery of lipid nanocapsules in rats.
    Hureaux J; Lacoeuille F; Lagarce F; Rousselet MC; Contini A; Saulnier P; Benoit JP; Urban T
    Int J Nanomedicine; 2017; 12():8159-8170. PubMed ID: 29184405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inner ear biocompatibility of lipid nanocapsules after round window membrane application.
    Zhang Y; Zhang W; Löbler M; Schmitz KP; Saulnier P; Perrier T; Pyykkö I; Zou J
    Int J Pharm; 2011 Feb; 404(1-2):211-9. PubMed ID: 21075187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced and preferential internalization of lipid nanocapsules into human glioblastoma cells: effect of a surface-functionalizing NFL peptide.
    Karim R; Lepeltier E; Esnault L; Pigeon P; Lemaire L; Lépinoux-Chambaud C; Clere N; Jaouen G; Eyer J; Piel G; Passirani C
    Nanoscale; 2018 Jul; 10(28):13485-13501. PubMed ID: 29972178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia.
    Briot T; Roger E; Lautram N; Verger A; Clavreul A; Lagarce F
    Int J Nanomedicine; 2017; 12():8427-8442. PubMed ID: 29200853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced anti-tumor efficacy of paclitaxel with PEGylated lipidic nanocapsules in presence of curcumin and poloxamer: In vitro and in vivo studies.
    Anwar M; Akhter S; Mallick N; Mohapatra S; Zafar S; Rizvi MMA; Ali A; Ahmad FJ
    Pharmacol Res; 2016 Nov; 113(Pt A):146-165. PubMed ID: 27546165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Boosting the In Vivo Transdermal Bioavailability of Asenapine Maleate Using Novel Lavender Oil-Based Lipid Nanocapsules for Management of Schizophrenia.
    El-Tokhy FS; Abdel-Mottaleb MMA; Abdel Mageed SS; Mahmoud AMA; El-Ghany EA; Geneidi AS
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low temperature, easy scaling up method for development of smart nanostructure hybrid lipid capsules for drug delivery application.
    Yadava SK; Basu SM; Chauhan M; Sharma K; Pradhan A; V R; Giri J
    Colloids Surf B Biointerfaces; 2020 Jun; 190():110927. PubMed ID: 32169777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules.
    Pinton L; Magri S; Masetto E; Vettore M; Schibuola I; Ingangi V; Marigo I; Matha K; Benoit JP; Della Puppa A; Bronte V; Lollo G; Mandruzzato S
    J Nanobiotechnology; 2020 Feb; 18(1):31. PubMed ID: 32066449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel.
    Hureaux J; Lagarce F; Gagnadoux F; Vecellio L; Clavreul A; Roger E; Kempf M; Racineux JL; Diot P; Benoit JP; Urban T
    Eur J Pharm Biopharm; 2009 Oct; 73(2):239-46. PubMed ID: 19560538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reciprocal competition between lipid nanocapsules and P-gp for paclitaxel transport across Caco-2 cells.
    Roger E; Lagarce F; Garcion E; Benoit JP
    Eur J Pharm Sci; 2010 Aug; 40(5):422-9. PubMed ID: 20438839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inter-nanocarrier and nanocarrier-to-cell transfer assays demonstrate the risk of an immediate unloading of dye from labeled lipid nanocapsules.
    Simonsson C; Bastiat G; Pitorre M; Klymchenko AS; Béjaud J; Mély Y; Benoit JP
    Eur J Pharm Biopharm; 2016 Jan; 98():47-56. PubMed ID: 26522878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis.
    Roger E; Lagarce F; Garcion E; Benoit JP
    J Control Release; 2009 Dec; 140(2):174-81. PubMed ID: 19699246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma.
    Huynh NT; Passirani C; Allard-Vannier E; Lemaire L; Roux J; Garcion E; Vessieres A; Benoit JP
    Int J Pharm; 2012 Feb; 423(1):55-62. PubMed ID: 21536115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery.
    Groo AC; Saulnier P; Gimel JC; Gravier J; Ailhas C; Benoit JP; Lagarce F
    Int J Nanomedicine; 2013; 8():4291-302. PubMed ID: 24235827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The adaptation of lipid nanocapsule formulations for blood administration in animals.
    Hureaux J; Lagarce F; Gagnadoux F; Clavreul A; Benoit JP; Urban T
    Int J Pharm; 2009 Sep; 379(2):266-9. PubMed ID: 19467305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of lipid nanocapsules in different cochlear cell populations after round window membrane permeation.
    Zou J; Saulnier P; Perrier T; Zhang Y; Manninen T; Toppila E; Pyykkö I
    J Biomed Mater Res B Appl Biomater; 2008 Oct; 87(1):10-8. PubMed ID: 18437698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficient ferrocifen anticancer drug and Bcl-2 gene therapy using lipid nanocapsules on human melanoma xenograft in mouse.
    Resnier P; Galopin N; Sibiril Y; Clavreul A; Cayon J; Briganti A; Legras P; Vessières A; Montier T; Jaouen G; Benoit JP; Passirani C
    Pharmacol Res; 2017 Dec; 126():54-65. PubMed ID: 28159700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding the Thermodynamic Mechanisms Leading to the Binding of Albumin to Lipid Nanocapsules.
    Umerska A; Sapin-Minet A; Parent M; Tajber L; Maincent P; Boudier A
    Langmuir; 2020 Apr; 36(15):4165-4173. PubMed ID: 32223171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Switching indication of PEGylated lipid nanocapsules-loaded with rolapitant and deferasirox against breast cancer: Enhanced in-vitro and in-vivo cytotoxicity.
    Kabil MF; Mahmoud MY; Bakr AF; Zaafar D; El-Sherbiny IM
    Life Sci; 2022 Sep; 305():120731. PubMed ID: 35753435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and characterization of sorafenib-loaded lipid nanocapsules for the treatment of glioblastoma.
    Clavreul A; Roger E; Pourbaghi-Masouleh M; Lemaire L; Tétaud C; Menei P
    Drug Deliv; 2018 Nov; 25(1):1756-1765. PubMed ID: 30338715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.